Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: Case report and review of literature

8Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Thalidomide is being increasingly used in hematology and oncology. Its use is associated with neuropathy, sedation, edema, fatigue, constipation, and deep venous thrombosis. Cytopenias are unusual, but there are case reports. However, there are no reports of isolated thrombocytopenia. We describe here a case of prolonged isolated thrombocytopenia most likely caused by thalidomide. The patient's in platelet count decreased promptly after an increase in the dose and improved after discontinuation of the drug. The relevant literature is reviewed. © 2007 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Prasad, H. K., Kaushal, V., & Mehta, P. (2007). Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: Case report and review of literature. American Journal of Hematology, 82(9), 855–857. https://doi.org/10.1002/ajh.20949

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free